FoundationOne Liquid CDx (F1 Liquid CDx) - based Clinical Trial Assay

FDA Premarket Approval P190032 S008

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceFoundationOne Liquid CDx (F1 Liquid CDx) - based Clinical Trial Assay
Generic NameNext Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
ApplicantFoundation Medicine Inc.150 Second Streetcambridge, MA 02141 PMA NumberP190032 Supplement NumberS008 Date Received09/26/2022 Decision Date12/19/2022 Product Code PQP  Advisory Committee Pathology Supplement Typereal-time Process Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No
Date Received2022-09-26
Decision Date2022-12-19
PMAP190032
SupplementS008
Product CodePQP 
Advisory CommitteePathology
Supplement TypeReal-time Process
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination ProductNo
Applicant AddressFoundation Medicine Inc.
150 Second Street
cambridge, MA 02141 PMA NumberP190032 Supplement NumberS008 Date Received09/26/2022 Decision Date12/19/2022 Product Code PQP  Advisory Committee Pathology Supplement Typereal-time Process Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No Combination ProductNo Approval Order Statement  
Approval For FoundationOne® Liquid CDx (FILCDx) Label Expansion To Obtain Companion Diagnostic Group Labeling Claim For Patients With Non-small Cell Lung Cancer Harboring EGFR Exon 19 Deletions Or EGFR Exon 21 L858R Mutations For Treatment With Any One Of The FDA-approved EGFR Tyrosine Kinase Inhibitors (TKI).

Supplemental Filings

Supplement NumberDateSupplement Type
P190032Original Filing
S008 2022-09-26 Real-time Process
S007 2022-08-29 Special (immediate Track)
S006 2022-08-22 Special (immediate Track)
S005
S004
S003 2021-10-28 Normal 180 Day Track
S002
S001 2020-08-28 Panel Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.